182 related articles for article (PubMed ID: 15797955)
1. The "obese insulin-sensitive" adolescent: importance of adiponectin and lipid partitioning.
Weiss R; Taksali SE; Dufour S; Yeckel CW; Papademetris X; Cline G; Tamborlane WV; Dziura J; Shulman GI; Caprio S
J Clin Endocrinol Metab; 2005 Jun; 90(6):3731-7. PubMed ID: 15797955
[TBL] [Abstract][Full Text] [Related]
2. Adiponectin in youth: relationship to visceral adiposity, insulin sensitivity, and beta-cell function.
Bacha F; Saad R; Gungor N; Arslanian SA
Diabetes Care; 2004 Feb; 27(2):547-52. PubMed ID: 14747242
[TBL] [Abstract][Full Text] [Related]
3. Low adiponectin levels in adolescent obesity: a marker of increased intramyocellular lipid accumulation.
Weiss R; Dufour S; Groszmann A; Petersen K; Dziura J; Taksali SE; Shulman G; Caprio S
J Clin Endocrinol Metab; 2003 May; 88(5):2014-8. PubMed ID: 12727947
[TBL] [Abstract][Full Text] [Related]
4. Morphometric documentation of abnormal intramyocellular fat storage and reduced glycogen in obese patients with Type II diabetes.
Levin K; Daa Schroeder H; Alford FP; Beck-Nielsen H
Diabetologia; 2001 Jul; 44(7):824-33. PubMed ID: 11508266
[TBL] [Abstract][Full Text] [Related]
5. Central role of fatty liver in the pathogenesis of insulin resistance in obese adolescents.
D'Adamo E; Cali AM; Weiss R; Santoro N; Pierpont B; Northrup V; Caprio S
Diabetes Care; 2010 Aug; 33(8):1817-22. PubMed ID: 20668154
[TBL] [Abstract][Full Text] [Related]
6. Lower-body fat mass as an independent marker of insulin sensitivity--the role of adiponectin.
Buemann B; Sørensen TI; Pedersen O; Black E; Holst C; Toubro S; Echwald S; Holst JJ; Rasmussen C; Astrup A
Int J Obes (Lond); 2005 Jun; 29(6):624-31. PubMed ID: 15824752
[TBL] [Abstract][Full Text] [Related]
7. Relationship of adiponectin with insulin sensitivity in humans, independent of lipid availability.
Furler SM; Gan SK; Poynten AM; Chisholm DJ; Campbell LV; Kriketos AD
Obesity (Silver Spring); 2006 Feb; 14(2):228-34. PubMed ID: 16571847
[TBL] [Abstract][Full Text] [Related]
8. Adiponectin and C-reactive protein in obesity, type 2 diabetes, and monodrug therapy.
Putz DM; Goldner WS; Bar RS; Haynes WG; Sivitz WI
Metabolism; 2004 Nov; 53(11):1454-61. PubMed ID: 15536601
[TBL] [Abstract][Full Text] [Related]
9. Effect of gender on lipid-induced insulin resistance in obese subjects.
Vistisen B; Hellgren LI; Vadset T; Scheede-Bergdahl C; Helge JW; Dela F; Stallknecht B
Eur J Endocrinol; 2008 Jan; 158(1):61-8. PubMed ID: 18166818
[TBL] [Abstract][Full Text] [Related]
10. Co-existence of severe insulin resistance and hyperinsulinaemia in pre-adolescent obese children.
Caprio S; Bronson M; Sherwin RS; Rife F; Tamborlane WV
Diabetologia; 1996 Dec; 39(12):1489-97. PubMed ID: 8960831
[TBL] [Abstract][Full Text] [Related]
11. Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients.
Bajaj M; Suraamornkul S; Piper P; Hardies LJ; Glass L; Cersosimo E; Pratipanawatr T; Miyazaki Y; DeFronzo RA
J Clin Endocrinol Metab; 2004 Jan; 89(1):200-6. PubMed ID: 14715850
[TBL] [Abstract][Full Text] [Related]
12. Reduced whole-body lipid oxidation is associated with insulin resistance, but not with intramyocellular lipid content in offspring of type 2 diabetic patients.
Lattuada G; Costantino F; Caumo A; Scifo P; Ragogna F; De Cobelli F; Del Maschio A; Luzi L; Perseghin G
Diabetologia; 2005 Apr; 48(4):741-7. PubMed ID: 15759111
[TBL] [Abstract][Full Text] [Related]
13. Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism.
Tschritter O; Fritsche A; Thamer C; Haap M; Shirkavand F; Rahe S; Staiger H; Maerker E; Häring H; Stumvoll M
Diabetes; 2003 Feb; 52(2):239-43. PubMed ID: 12540592
[TBL] [Abstract][Full Text] [Related]
14. Insulin resistance in adolescents with type 2 diabetes is associated with impaired exercise capacity.
Nadeau KJ; Zeitler PS; Bauer TA; Brown MS; Dorosz JL; Draznin B; Reusch JE; Regensteiner JG
J Clin Endocrinol Metab; 2009 Oct; 94(10):3687-95. PubMed ID: 19584191
[TBL] [Abstract][Full Text] [Related]
15. Youth type 2 diabetes: insulin resistance, beta-cell failure, or both?
Gungor N; Bacha F; Saad R; Janosky J; Arslanian S
Diabetes Care; 2005 Mar; 28(3):638-44. PubMed ID: 15735201
[TBL] [Abstract][Full Text] [Related]
16. The insulin effect on cerebrocortical theta activity is associated with serum concentrations of saturated nonesterified Fatty acids.
Tschritter O; Preissl H; Hennige AM; Sartorius T; Grichisch Y; Stefan N; Guthoff M; Düsing S; Machann J; Schleicher E; Cegan A; Birbaumer N; Fritsche A; Häring HU
J Clin Endocrinol Metab; 2009 Nov; 94(11):4600-7. PubMed ID: 19820026
[TBL] [Abstract][Full Text] [Related]
17. Fat distribution, lipid accumulation in the liver, and exercise capacity do not explain the insulin resistance in healthy males with a family history for type 2 diabetes.
Johanson EH; Jansson PA; Lönn L; Matsuzawa Y; Funahashi T; Taskinen MR; Smith U; Axelsen M
J Clin Endocrinol Metab; 2003 Sep; 88(9):4232-8. PubMed ID: 12970292
[TBL] [Abstract][Full Text] [Related]
18. Ceramide content is increased in skeletal muscle from obese insulin-resistant humans.
Adams JM; Pratipanawatr T; Berria R; Wang E; DeFronzo RA; Sullards MC; Mandarino LJ
Diabetes; 2004 Jan; 53(1):25-31. PubMed ID: 14693694
[TBL] [Abstract][Full Text] [Related]
19. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women?
Brochu M; Tchernof A; Dionne IJ; Sites CK; Eltabbakh GH; Sims EA; Poehlman ET
J Clin Endocrinol Metab; 2001 Mar; 86(3):1020-5. PubMed ID: 11238480
[TBL] [Abstract][Full Text] [Related]
20. Correlations between fatty acid and glucose metabolism. Potential explanation of insulin resistance of puberty.
Arslanian SA; Kalhan SC
Diabetes; 1994 Jul; 43(7):908-14. PubMed ID: 8013756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
